NASDAQ
GenSight Biologics S.A. (GSGTF) has a price/sales ratio of 24002.95x as of Friday, May 22, 2026. This represents a 72314.99% increase compared to its 12-month average of 33.15x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.